Radius Business Review Ends In Sale To Investment Funds

 
• By Jessica Merrill

Gurnet Point Capital and Patient Square Capital will buy Radius Health for approximately $890m, including a contingent value right dependent on sales growth for osteoporosis drug Tymlos.

sold sign
Radius Health was sold to two investment firms • Source: Shutterstock

More from Deals

More from Business